iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development. Imprint: https://iomx.com/imprint
View Top Employees from iOmx Therapeutics AG| Website | http://www.iomx.com |
| Revenue | $5 million |
| Funding | $44.6 million |
| Employees | 57 (44 on RocketReach) |
| Founded | 2016 |
| Address | 13 Fraunhoferstrasse, Martinsried/ Munich, Bavaria 82152, DE |
| Phone | +49 89 899970900 |
| Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Immuno Oncology, Pharmaceuticals, Science and Engineering, Drug development, Healthcare, Health Care, Cancer Therapy, Pharmaceutical, Therapeutics |
| Competitors | Aura Biosciences, Jounce Therapeutics, Inc., Juno Therapeutics, Inc., Perthera AI, 华润生物医药(深圳)有限公司 |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular iOmx Therapeutics AG employee's phone or email?
iOmx Therapeutics AG Questions
The iOmx Therapeutics AG annual revenue was $5 million in 2024.
Nisit Khandelwal is the Founder and Managing Director of iOmx Therapeutics AG.
44 people are employed at iOmx Therapeutics AG.
iOmx Therapeutics AG is based in Martinsried/ Munich, Bavaria.
The NAICS codes for iOmx Therapeutics AG are [54, 54171, 5417, 541, 541714].
The SIC codes for iOmx Therapeutics AG are [87, 873].
Top iOmx Therapeutics AG Employees
-
5+5
-
42
-
View
Kai Zanzinger
Director Project Management - Project Lead Product Development at iOmx Therapeutics AG
Hamburg, Hamburg, Germany1 -
11
-
2
Related Companies
